These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33456999)

  • 41. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.
    Goto H; Tokunaga M; Miki Y; Makuuchi R; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
    Gastric Cancer; 2014 Mar; 18(2):375-81. PubMed ID: 24658651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Total laparoscopic versus laparoscopic-assisted transabdominal posterior mediastinal digestive tract reconstruction in the treatment of Siewert II adenocarcinoma of the esophagogastric junction: A retrospective study.
    Wang L; Chen X; Miao W; Ma Y; Ma X; Wang C; Cao X; Xu H; Wei J; Yan S
    Front Surg; 2022; 9():874857. PubMed ID: 36061040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of robotic surgery for Siewert type II/III adenocarcinoma of esophagogastric junction: transhiatal robotic versus laparoscopic approach.
    Nishi M; Wada Y; Yoshikawa K; Takasu C; Tokunaga T; Nakao T; Kashihara H; Yoshimoto T; Shimada M
    BMC Surg; 2023 May; 23(1):128. PubMed ID: 37194030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laparoscopic versus open gastrectomy for Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis.
    Liao C; Feng Q; Xie S; Chen J; Shi Y
    Surg Endosc; 2021 Feb; 35(2):860-871. PubMed ID: 32076857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction].
    Yan Q; Lyu ZJ; Zheng JB; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):1008-1012. PubMed ID: 33054000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of laparoscopic proximal gastrectomy with SOFY versus laparoscopic total gastrectomy with Roux-en-Y for treating cT1-2 Siewert II/III adenocarcinoma of the esophagogastric junction: a single-center prospective cohort study.
    Zhang H; Zheng Z; Liu X; Xin C; Huang Y; Li Y; Yin J; Zhang J
    Langenbecks Arch Surg; 2023 Jan; 408(1):69. PubMed ID: 36715889
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of laparoscopic proximal gastrectomy with double-tract reconstruction versus laparoscopic total gastrectomy with Roux-en-Y reconstruction for early upper gastric cancer].
    Qiu GL; Wei C; Zhu MK; Han SN; Li XW; Wang HJ; Wang PX; Liu JH; Zhou HY; Liao XH; Che XM; Fan L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 May; 25(5):412-420. PubMed ID: 35599396
    [No Abstract]   [Full Text] [Related]  

  • 48. [Proximal gastrectomy and digestive tract reconstruction: status survey of perceptions and treatment selection in Chinese surgeons].
    Li ZG; Dong JH; Huang QX; Tao K; Ma J; Zhang WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Aug; 23(8):757-765. PubMed ID: 32810947
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy analysis of Cheng's GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction.
    Xu Z; Hu C; Zhang Y; Huang L; Yang L; Yu J; Yu P; Chen J; Du Y; Cheng X
    Chin J Cancer Res; 2022 Jun; 34(3):289-297. PubMed ID: 35873890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can Clinical Stage in the 8
    Watanabe H; Hasegawa S; Kumazu Y; Hashimoto I; Komori K; Suematsu H; Kano K; Fujikawa H; Aoyama T; Yamada T; Yukawa N; Yoshikawa T; Rino Y; Saito A; Ogata T; Oshima T
    In Vivo; 2023; 37(4):1790-1796. PubMed ID: 37369497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of quality-of-life after proximal gastrectomy with double tract reconstruction versus gastric tube reconstruction in patients with proximal gastric cancer].
    Gao HF; Tao L; Bao LS; Wang F; Liu S; Lu XF; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1162-1170. PubMed ID: 38110278
    [No Abstract]   [Full Text] [Related]  

  • 52. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
    Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
    Front Oncol; 2021; 11():748694. PubMed ID: 34926257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Long-Term Outcomes of Surgery Versus Endoscopic Treatment in Patients With Siewert Type II T1M0N0 Adenocarcinoma of the Esophagogastric Junction.
    Chen H; Yu X; Yang R; Li S; Zhang G; Si X; Zhou X
    Cancer Control; 2022; 29():10732748221143389. PubMed ID: 36523149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laparoscopic versus Open Approach for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis.
    Wu M; Zhang W; Song YY
    Dig Surg; 2022; 39(5-6):210-223. PubMed ID: 36599323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kuwata T; Tokunaga M; Kaito A; Watanabe M; Tonouchi A; Sato R; Nagino M
    Surg Endosc; 2021 Jan; 35(1):340-348. PubMed ID: 32025923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hand-sewn esophagojejunostomy in transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction with esophageal invasion > 3 cm.
    Chen Y; Xiong W; Zeng H; Luo L; Lin Z; Li J; Zheng Y; Zhong Y; Yang T; Wang W
    Surg Endosc; 2023 May; 37(5):4104-4110. PubMed ID: 37072636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Safety and feasibility of intrathoracic modified overlap esophagojejunostomy in laparoscopic radical resection of Siewert type Ⅱ adenocarcinoma of esophagogastric junction].
    Chen Y; Xiong WW; Zheng YS; Luo LJ; Li J; Zhu XF; Luo SJ; Xu YT; Wan J; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):173-178. PubMed ID: 35176830
    [No Abstract]   [Full Text] [Related]  

  • 59. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
    Jin P; Ma G; Liu Y; Ke B; Liu HM; Liang H; Zhang RP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):54-62. PubMed ID: 38262901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.